sang et organes humains – Pérénité du modèle français de collecte du plasma

This written question concerns the sustainability of the French model for collecting human plasma, a vital component for medicines. It seeks to understand the government's strategy to ensure a stable and independent supply. The question affects patients relying on plasma-derived medicines and the French healthcare system. It aims to clarify policies supporting voluntary, unpaid plasma donation.